IgA nephropathy: is a new approach beyond proteinuria necessary?

被引：3
|
作者：
Gutierrez, Eduardo [1 ]
机构：
[1] Hosp Univ 12 Octubre, Nephrol Dept, Madrid, Spain
来源：
PEDIATRIC NEPHROLOGY | 2019年 / 34卷 / 05期
关键词：
IMMUNOGLOBULIN-A NEPHROPATHY; OXFORD CLASSIFICATION; RISK-FACTORS; NATURAL-HISTORY; CHILDREN; ASSOCIATION; REMISSION; PROGRESSION; INHIBITORS; HEMATURIA;
D O I：
10.1007/s00467-019-4202-9
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：921 / 924
页数：4
相关论文
共 50 条
  • [31] Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)
    Shirai, Sayuri
    Yasuda, Takashi
    Kumagai, Hiroo
    Matsunobu, Hanako
    Ichikawa, Daisuke
    Shibagaki, Yugo
    Yasuda, Yoshinari
    Matsuzaki, Keiichi
    Hirano, Keita
    Kawamura, Tetsuya
    Suzuki, Yusuke
    Maruyama, Shoichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (04) : 340 - 348
  • [32] IgA Nephropathy
    Rodrigues, Jennifer C.
    Haas, Mark
    Reich, Heather N.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (04): : 677 - 686
  • [33] Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy
    Luo, Mian-Na
    Yao, Cui-Wei
    Xu, Bi-Hua
    Xu, Yong-Zhi
    Liu, Wei Jing
    Feng, Yong-Min
    Tao, Jing-Li
    Liu, Hua-Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (03) : 553 - 559
  • [34] IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?
    Alexandra Cambier
    Jean-Philippe Roy
    Claire Dossier
    Natacha Patey
    Marion Rabant
    Olivia Boyer
    Jean Daniel Delbet
    Anne-Laure Lapeyraque
    Julien Hogan
    Pediatric Nephrology, 2024, 39 : 781 - 787
  • [35] Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria
    Kayu Tanaka
    Takahito Moriyama
    Chihiro Iwasaki
    Takashi Takei
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2015, 19 : 815 - 821
  • [36] Podocyte number predicts progression of proteinuria in IgA nephropathy
    Xu, Lan
    Yang, Hai-Chun
    Hao, Chuan-Ming
    Lin, Shan-Tan
    Gu, Yong
    Ma, Ji
    MODERN PATHOLOGY, 2010, 23 (09) : 1241 - 1250
  • [37] Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
    Tang, S
    Leung, JCK
    Chan, LYY
    Lui, YH
    Tang, CSO
    Kan, CH
    Ho, YW
    Lai, KN
    KIDNEY INTERNATIONAL, 2005, 68 (02) : 802 - 812
  • [38] Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
    Nam, Ki Heon
    Kie, Jeong Hae
    Lee, Mi Jung
    Chang, Tae-Ik
    Kang, Ea Wha
    Kim, Dong Wook
    Lim, Beom Jin
    Park, Jung Tak
    Kwon, Young Eun
    Kim, Yung Ly
    Park, Kyoung Sook
    An, Seong Yeong
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Choi, Kyu Hun
    Jeong, Hyeon Joo
    Han, Dae-Suk
    Han, Seung Hyeok
    PLOS ONE, 2014, 9 (07):
  • [39] Treatment of IgA nephropathy in children: a land without KDIGO guidance
    Coppo, Rosanna
    PEDIATRIC NEPHROLOGY, 2021, 36 (03) : 491 - 496
  • [40] A lack of KDIGO guidelines for adolescents and young adults with IgA nephropathy
    Dixon, Angelina
    Blanchette, Eliza
    Kendrick, Jessica
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : 297 - 304
12345